ERNAW

Ernexa Therapeutics Inc. Warrants (ERNAW)

Stock · NASDAQ · Health Care

$0.0589as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Industry
Biotechnology: Pharmaceutical Preparations

Ernexa Therapeutics Inc. Warrants Competitors

Chosen by industry and closest market cap.

  • ERNAW
    Ernexa Therapeutics Inc. Warrants
    $0.0589
    ▼ 24.49%
    Market cap $58.3KP/E
  • BCTXZ
    BriaCell Therapeutics Corp. Warrant expiring 2030
    $0.135
    ▲ 12.31%
    Market cap $782.1KP/E
    $0.0551$0.52
  • BDRX
    Biodexa Pharmaceuticals plc American Depositary Shs
    $0.8351
    ▼ 7.21%
    Market cap $1.06MP/E
    $0.8303$59.4
  • CDT
    CDT Equity Inc. Common Stock
    $1.69
    ▼ 10.37%
    Market cap $1.81MP/E
    $1.62$2,928
  • MTNB
    Matinas Biopharma Holdings Inc. Common Stock
    $0.1966
    ▼ 1.70%
    Market cap $1.93MP/E
    $0.178$2.14
  • OGEN
    Oragenics Inc. Common Stock
    $0.5296
    ▼ 0.08%
    Market cap $2.39MP/E
    $0.4801$1.45
  • SBFM
    Sunshine Biopharma Inc. Common Stock
    $1.16
    ▼ 8.66%
    Market cap $2.48MP/E
    $1.01$24.3

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
6.80M
Total value held
$195.3K
Institutional holders
5
Top holders this quarter
  • Unknown4.00M
  • Unknown2.00M
  • Unknown400.0K
  • Unknown253.8K
  • Unknown149.3K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.